| Health / Medical Topics |
IMC-3G3
A substance being studied in the treatment of glioblastoma (a type of brain tumor) that has come back. It binds to receptors for a protein called platelet-derived growth factor (PDGF). This keeps PDGF from binding to the cells. This may stop the growth of cancer cells and blood vessels that have the receptors for PDGF. It is a type of monoclonal antibody. Also called anti-PDGFR alpha monoclonal antibody IMC-3G3 and anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3. (NCI Dictionary)
YOU MAY ALSO LIKE
A monoclonal antibody that selectively binds with KDR and blocks the vascular endothelial growth factor-induced endothelial cell proliferation and prevents angiogenesis. …
A substance being studied in the treatment of breast cancer that has come back. It binds to receptors for a protein called…
A drug used to treat mantle cell lymphoma in patients who have already received other treatment. It is also being studied in…
A drug used to treat different types of leukemia and other cancers of the blood, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma…
An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain…
A type of test that makes pictures of areas inside the body. Some examples of imaging tests are CT scans and…
